Saturday, September 21st, 2024

Category: News

Glucocorticoid for Systemic Lupus Erythematosus Market 2024 [Key Trends] | Pfizer, Sanofi, Teva

Press Release, July, 2024 (Orbis Research) – This Glucocorticoid for Systemic Lupus Erythematosus Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends, thus facilitating...

Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Growth Factors | Alkem Laboratories, Anhui Biochem Pharmaceutical, Beijing SL Pharmaceutical

Press Release, July, 2024 (Orbis Research) – This Tenofovir Disoproxil Fumarate and Its Combination Drugs Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends,...

Elvitegravir Combination Drugs Market (YoY) Growth Analysis | Gilead Sciences, Bristol-Myers Squibb, Janssen Pharmaceutica (Johnson & Johnson)

Press Release, July, 2024 (Orbis Research) – This Elvitegravir Combination Drugs Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends, thus facilitating informed decision-making...

Melphalan Market [Top Players ] GlaxoSmithKline, Celon Laboratories, Natco Pharma

Press Release, July, 2024 (Orbis Research) – This Melphalan Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends, thus facilitating informed decision-making for stakeholders....

Metoprolol Combination Drugs Market [2024-2031] | Novartis, Selokeen, Alphapharm

Press Release, July, 2024 (Orbis Research) – This Metoprolol Combination Drugs Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends, thus facilitating informed decision-making...

PD-1 Inhibitor Market 2024 Revenue and Share Analysis | Merck, Novartis, Onxeo

Press Release, July, 2024 (Orbis Research) – This PD-1 Inhibitor Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends, thus facilitating informed decision-making for...

Selective Cox-2 Inhibitors Market Key Strategy Matrices | Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals

Press Release, July, 2024 (Orbis Research) – This Selective Cox-2 Inhibitors Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends, thus facilitating informed decision-making...

Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size (Revenue) | ImClone Systems ‎(Eli Lilly)

Press Release, July, 2024 (Orbis Research) – This Targeted Drug VEGFR2 Inhibitors for NSCLC Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends, thus...

Targeted Drug BRAF Inhibitors for NSCLC Market [Top Trends] | BeiGene, Novartis

Press Release, July, 2024 (Orbis Research) – This Targeted Drug BRAF Inhibitors for NSCLC Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends, thus...

Targeted Drug HER2 Inhibitors for NSCLC Market 2024 [Key Trends] | Boehringer-Ingelheim, Roche, Mylan

Press Release, July, 2024 (Orbis Research) – This Targeted Drug HER2 Inhibitors for NSCLC Market report offers a comprehensive understanding of the market dynamics, providing insights into its past, present, and future trends, thus...